Camostat mesylate
[4-[2-[2-(dimethylamino)-2-oxoethoxy]-2-oxoethyl]phenyl] 4-(diaminomethylideneamino)benzoate;methanesulfonic acid
Molecular Identity
Camostat mesylate
[4-[2-[2-(dimethylamino)-2-oxoethoxy]-2-oxoethyl]phenyl] 4-(diaminomethylideneamino)benzoate;methanesulfonic acid
PubChem CID: 5284360
Camostat mesylate is a methanesulfonate (mesylate) salt prepared from equimolar amounts of camostat and methanesulfonic acid. It is a serine protease inhibitor approved and marketed in Japan in 1985 for the alleviation of acute symptoms associated with chronic pancreatitis. In 1994, it was approved for the treatment of postoperative reflux esophagitis. It has a role as an anticoronaviral agent, an antiviral agent, an antineoplastic agent, an antihypertensive agent, an antifibrinolytic drug, a serine protease inhibitor and an anti-inflammatory agent. It contains a camostat(1+).
2D Structure
Properties
C21H26N4O8S
Molecular Formula
494.50
Molecular Weight
g/mol
494.1471
Exact Mass
Da
200
TPSA
May have limited oral absorption
3
H-Bond Donors
9
H-Bond Acceptors
695
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
Camostat mesylatecamostat mesilate59721-29-8FoipanCamostat MethanesulfonateFOY 305Camostat monomethanesulfonateDTXSID0020238DTXCID20238CHEBI:31347FOY-305451M50A1EQN,N-Dimethylcarbamoylmethyl 4-(4-guanidinobenzoyloxy)phenylacetate methanesulfonatefoypanFOY305
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Camostat mesylate
Loading drug network...